Log in to your Inderes Free account to see all free content on this page.
Bavarian Nordic
181.55 DKK
+2.20 %
Less than 1K followers
BAVA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Bavarian Nordic
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,363.4 | 2,093.9 | 5,716.2 | 1,346.6 | 1,651.5 | 1,794.9 | 1,451.0 | 6,244.0 |
| EBITDA | 250.5 | 911.3 | 1,603.1 | 419.5 | 541.8 | 1,325.5 | 255.1 | 2,541.9 |
| EBIT | 93.6 | 709.2 | 939.8 | 258.9 | 371.0 | 1,154.6 | 19.4 | 1,803.8 |
| EBIT-% | 6.9 % | 33.9 % | 16.4 % | 19.2 % | 22.5 % | 64.3 % | 1.3 % | 28.9 % |
| Profit before taxes | 72.5 | 747.1 | 971.4 | 229.5 | 373.4 | 1,169.9 | 28.2 | 1,801.0 |
| Net income | 70.5 | 770.8 | 988.0 | 218.8 | 362.6 | 1,092.8 | -298.8 | 1,375.4 |
Login required
This content is only available for logged in users